主页文献库搜索
Gemcitabine plus erlotinib (GE) followed by capecitabine (C) versus capecitab...

Boeck(S H),Vehling-Kaiser(U),Waldschmidt(D... J Clin Oncol 0000-00-00

...KRAS mutation (mut). Pts with KRAS wildtype (wt, n=53) had an improved OS (wt: 8.0 mo vs. mut: 6.6 mo; HR 1.62, p=0.011)...

A phase III randomized, double-blind, placebo-controlled trial of the epiderm...

Goss(G D),Lorimer(I),Tsao(M S),O'Callaghan... J Clin Oncol 0000-00-00

...KRAS and EGFR copy are available on 350 and 348 pts respectively. KRAS mutations were neither prognostic HR 1.12 (95% C....

Final STEPP results of prophylacatic versus reactive skin toxicity (ST) treat...

Mitchell(E P),Lacouture(M),Shearer(H),Iann... J Clin Oncol 0000-00-00

...KRAS evaluable pts, 49 (56%) pts had WT KRAS and 38 (44%) pts had MT KRAS. Efficacy and safety are shown. Mean (SD) chan...

Smoking-related and non-smoking-related carcinogensis in adenocarcinoma of th...

Mitsudomi(T),Onozato(R),Kosaka(T),Yatabe(Y... J Clin Oncol 0000-00-00

...KRAS gene and transmembrare region of the MET in a cohort of 211 lung adenocarcinoma. In addition, we searched for mutat...

EGFR, KRAS, PIK3CA mutations and response to tyrosine kinase inhibitors (TKIs...

Darwish(S),Ludovini(V),Pistola(L),Bianconi... J Clin Oncol 0000-00-00

...KRAS, PIK3CA gene mutations in pts with advanced NSCLC who had been treated with gefitinib or erlotinib after failure of...

[Molecular Pathogenesis of Colorectal Cancer].

Král(J),Slyšková(J),Vodička(P),Špičák(J) Klin Onkol 0000-00-00

...KRAS, MMR, microRNA, CIMP etc.). Knowledge of the molecular pathogenesis of CRC (hereditary, sporadic) is crucial for tr...

Molecular dissection of the RAS/RAF/MAPK pathway in primary and metastatic me...

Rother(J),Bailey(J),Alvarado(G),Prieto(V G... J Clin Oncol 0000-00-00

...KRAS and NRAS (exons 1 and 2) were assessed by quantitative pyrosequencing. MAPK levels were assessed by immunohistochem...

Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis v...

Tan(Mingjia),Xu(Jie),Siddiqui(Javed),Feng(... Mol Cancer 0000-00-00

...Kras to promote lung tumorigenesis, but antagonized Kras to inhibit skin tumorigenesis, suggesting a tissue/context depe...

EUS for pancreatic cystic neoplasms: The roadmap to the future is much more t...

Kirtane(Tejas),Bhutani(Manoop S) Asian Pac J Trop Med 0000-00-00

...KRAS and GNAS hold promise, but which molecular marker or a combination of markers is most useful and cost effective rem...

An open label phase II study evaluating first-line EGFR tyrosine kinase inhib...

Szutowicz-Zielińska(Ewa),Konopa(Krzysztof)... Oncotarget 0000-00-00

...KRAS and BRAF mutations are additionally presented.,This trial argues against using high gene copy number for selection ...

上一页 938 939 940 941 942 943 944 945 946 下一页 942 / 共 953

联系地址

山东省济南市章丘区文博路2号

齐鲁师范学院 genelibs生信实验室

山东省济南市高新区舜华路750号

大学科技园北区F座4单元2楼

电话: 0531-88819269

微信公众号

关注微信订阅号,实时查看信息,关注医学生物学动态。


商务邮箱

E-mail: [email protected]